Preclinical Basis of the Efficacy and Pharmacodynamics of Finotonlimab, a Humanized Anti-PD-1 Monoclonal Antibody with Potent Implications for Clinical Benefit https://www.biorxiv.org/content/10.1101/2023.01.16.524197v1?med=mas
Preclinical Basis of the Efficacy and Pharmacodynamics of Finotonlimab, a Humanized Anti-PD-1 Monoclonal Antibody with Potent Implications for Clinical Benefit https://www.biorxiv.org/content/10.1101/2023.01.16.524197v1?med=mas